Congenital granular cell epulis: a rare paediatric tumour of newborn

Arun Mamachan Xavier1, Mahija Janardhanan2, Ravi Veeraraghavan3

  • 1Department of Pediatric and Preventive Dentistry, Amrita Vishwa Vidyapeetham Amrita School of Dentistry, Kochi, Kerala, India arunmamachan@yahoo.co.in.

BMJ Case Reports
|January 5, 2022
PubMed

Insights

Congenital granular cell epulis is a rare neonatal gingival tumor that can cause feeding and breathing issues. Prompt surgical excision and histopathological diagnosis are crucial for infant well-being.

Area of Science:

  • Pediatric Dentistry
  • Oral Pathology
  • Neonatal Care

Background:

  • Congenital granular cell epulis is a rare, benign oral tumor occurring in neonates.
  • These tumors can obstruct the infant's airway, impede feeding, and affect mouth closure.

Observation:

  • A case report details a 35-day-old female neonate with a large, exophytic lesion on the maxillary alveolar ridge.
  • The lesion presented significant challenges for the infant's feeding and respiration.

Findings:

  • Surgical excision of the lesion was performed under intravenous sedation.
  • Histopathological analysis confirmed the diagnosis of congenital granular cell epulis.

Implications:

  • Early recognition and prompt surgical intervention are vital for preventing complications in neonates.
  • Multidisciplinary collaboration among pediatricians, dentists, and pathologists is essential for optimal management.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.8K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
295
Classification of Leukocytes01:30

Classification of Leukocytes

Leukocytes are classified into two groups based on the presence or absence of cytoplasmic granules. Granular leukocytes, which contain granules, belong to the myeloid lineage and are divided into three subtypes: neutrophils, eosinophils, and basophils. These cells are roughly spherical and characterized by the granules in their cytoplasm.
Neutrophils are the most abundant type of granular leukocytes, comprising 50-70% of all leukocytes. They feature small, evenly distributed granules and a...
3.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17